Insider trading

Period: 120 months Stock: CAH + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

57 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

57 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

57 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

57 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
57 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
57 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

57 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
20 Aug 2018
Giacomin Jon L CEO, Medical Segment
Sold, plan not stated
$150.14K 2,890 at 51.95
3.8%
20 Feb 2018
Giacomin Jon L CEO, Medical Segment
Sold, plan not stated 2×
$549.92K 7,995 at 68.78
12.7%
14 Feb 2018
MORRISON PATRICIA Chief Information Officer
Sold, plan not stated
$1.89M 28,532 at 66.30
44.1%
22 Jan 2018
Kaufmann Michael C Chief Executive Officer
Sold, plan not stated
$1.37M 18,586 at 73.90
8.1%
12 May 2017
Giacomin Jon L CEO, Pharmaceutical Segment
Sold, plan not stated
$1.70M 23,270 at 72.87
42.0%
10 Feb 2017
Barrett George S Chairman and CEO
Sold, plan not stated
$16.84M 217,994 at 77.23
32.0%
10 Nov 2016
Barrett George S Chairman and CEO
Sold, plan not stated 3×
$15.54M 217,995 at 71.29
32.0%
Showing 51–57 of 57. ← Newer Page 2 of 2